Isis Pharma Changes "Unfortunate" Name to Avoid Confusion
Name of Egyptian goddess of healing afflicts California biotech firm
The drugmaker - named after the Egyptian protector and healer goddess Isis, who was revered as a protector and healer - has been around for more than a quarter century.
(Reuters) - After deliberating for most of the year, Isis Pharmaceuticals Inc said on Friday it would change its name to avoid being confused with the Islamist militant group known as ISIS.
The biotechnology company said it would be called Ionis Pharmaceuticals Inc from Dec. 22 and also changed its stock exchange ticker symbol to "IONS" from "ISIS".
On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
"It's been an ongoing discussion for most of this year", Chief Business Officer Sarah Boyce told Reuters.
"When you talk about the company you want people to immediately think about the incredible work you're doing to deliver transformational drugs to patients ... not as an unfortunate namesake."
The Carlsbad, California-based company's stock dropped about 4% on the first trading day after the Paris attacks, for which ISIS claimed responsibility.
The drugmaker - named after the Egyptian protector and healer goddess Isis, who was revered as a protector and healer - has been around for more than a quarter century.
Today it is a $7 billion company with one cholesterol drug on the market and treatments in development for a plethora of diseases, including cancer and heart conditions.
It’s Time to Stand Up for Science
If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.
I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.
If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.
